Newsletter Archive

1. 11.26.25 -- The Quest For A Type 1 Diabetes Cure Without Immunosuppression 11/26/2025
   11/26/25 Life Science Leader Newsletter
2. 11.24.25 -- Reading The FDA Tea Leaves On Psychedelics 11/24/2025
   11/24/25 Life Science Leader Newsletter
3. 11.21.25 -- 100% Drug Tariffs Are A Dire Threat — And Patients Can't Wait 11/21/2025
   11/21/25 Life Science Leader Newsletter
4. 11.20.25 -- Optimize Formulation And Integrity Workflows 11/20/2025

   11/20/25 Life Science Leader Newsletter

5. 11.20.25 -- A Deep Dive into AI, Patient Recruitment, ICH GCP & More 11/20/2025

   11/20/25 Life Science Leader Newsletter

6. 11.19.25 -- Biotech Funding, China Trials, And NAYA's Strategy 11/19/2025
   11/19/25 Life Science Leader Newsletter
7. 11.19.25 -- Scaling Smarter In Biologics Manufacturing 11/19/2025

   11/19/25 Life Science Leader Newsletter

8. 11.18.25 -- Plan For Patient Recruitment Step By Step 11/18/2025

   11/18/25 Life Science Leader Newsletter

9. 11.17.25 -- Patients And Industry Need A New Model For Rare Disease Gene Therapy 11/17/2025
   11/17/25 Life Science Leader Newsletter
10. 11.14.25 -- Partnering To Commercialize Radiopharmaceuticals 11/14/2025
    11/14/25 Life Science Leader Newsletter